Tag: EU JCA

EU JCA Is Now Operational: What the First Assessments Reveal About Evidence, RWE and Market Access The European Union’s Joint Clinical Assessment framework has moved decisively from policy into practice. Since the EU Health Technology Assessment Regulation became applicable in January 2025, pharmaceutical and biotechnology companies have been preparing for new timelines, evidence requirements and…